tirzepatide cedar rapids Tirz Initial Program | CoraDoc™ Tirzepatide — CRL

Mazdutide and Tirzepatide are both administered via subcutaneous injection, but their dosing schedules differ

Key findings from SURMOUNT-1 include a mean weight loss of 15.0% at the 5mg dose, 19.5% at the 10mg dose, and 20.9% at the 15mg dose over 72 weeks

This population was the primary focus of the SURMOUNT trials and tends to see the most dramatic absolute weight loss

Originally developed for type 2 diabetes management, this medication is now a cornerstone of modern weight management programs, offering a dual-action approach that helps patients achieve significant results when combined with a balanced diet and regular physical activity

Tirzepatide is only FDA approved for treatment of diabetes

Compounded tirzepatide may be part of a provider-guided plan during this stage